Meeting with Dorota Denning (Cabinet of Commissioner Valdis Dombrovskis) and 2 other interest representatives

28 Oct 2025 · Roundtable on Simplification for Pharmaceutical Innovation

Response to Commission Communication on a EU Cardiovascular Health Plan

15 Sept 2025

Meeting with Cecile Billaux (Head of Unit Directorate-General for International Partnerships)

10 Sept 2025 · Overview of Sanofi’s actions in global health and on local manufacturing in Africa

Meeting with Stéphane Séjourné (Executive Vice-President) and 45 other attendees

5 Sept 2025 · - Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EU

Meeting with Lucilla Sioli (Director Communications Networks, Content and Technology) and 1 other attendee

4 Sept 2025 · Virtual Human Twins

Meeting with Rainer Becker (Director Health and Food Safety) and AstraZeneca PLC

4 Sept 2025 · Exchange of views on multinational clinical trials in the context of the upcoming Biotech Act

Meeting with Florika Fink-Hooijer (Director-General Health Emergency Preparedness and Response Authority)

29 Jul 2025 · Health security and innovation across Europe, SANOFI’s relevant activities

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

8 Jul 2025 · Challenges of Sanofi in Europe and opportunities to enhance investment and innovation in the pharmaceutical sector

Meeting with Stéphane Séjourné (Executive Vice-President) and 21 other attendees

26 Jun 2025 · Compétitivité; relations USE-UE, CSRD/CS3D, Simplification

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

5 Jun 2025 · Challenges for the EU pharmaceutical industry

Response to Apply AI Strategy: strengthening the AI continent

4 Jun 2025

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis)

3 Jun 2025 · Competitiveness of the pharmaceutical sector

Meeting with Gabriela Tschirkova (Cabinet of Commissioner Valdis Dombrovskis)

3 Jun 2025 · Simplification

Meeting with Ann-Sofie Ronnlund (Cabinet of Commissioner Ekaterina Zaharieva)

28 May 2025 · Life sciences

Meeting with Egelyn Braun (Cabinet of Commissioner Michael McGrath)

13 May 2025 · Exchange of views on competitiveness, simplification and collective redress

Response to Evaluation of Regulation (EC) 2004/851 establishing a European Centre for disease prevention and control

9 May 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and 9 other attendees

4 Apr 2025 · Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis), Nicolo Brignoli (Cabinet of Commissioner Valdis Dombrovskis)

2 Apr 2025 · Competitiveness

Meeting with Lucie Šestáková (Cabinet of Commissioner Jozef Síkela), Natividad Lorenzo (Cabinet of Commissioner Jozef Síkela) and 16 other attendees

28 Mar 2025 · Global Gateway

Meeting with Felice Zaccheo (Head of Unit Directorate-General for International Partnerships)

19 Mar 2025 · To discuss Sanofi’s involvement in LAC and opportunities for actionable cooperations under the GGIA to contribute to health self-sufficiency in LAC.

Meeting with Olivier Girard (Head of Unit Health Emergency Preparedness and Response Authority)

12 Mar 2025 · Discussion on Joint procurement to improve availability of antibiotics and avoid shortages

Meeting with Kristoffer Storm (Member of the European Parliament)

11 Mar 2025 · Pharmaceutical Industry

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and 2 other attendees

27 Jan 2025 · Exploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with András Tivadar Kulja (Member of the European Parliament)

5 Dec 2024 · European health policy

Meeting with Eszter Lakos (Member of the European Parliament)

11 Nov 2024 · Pharmaceutical sector

Meeting with Oliver Schenk (Member of the European Parliament) and 4 other interest representatives

4 Nov 2024 · Pharmastandort Deutschland

Meeting with Billy Kelleher (Member of the European Parliament)

1 Oct 2024 · Pharma strategy

Meeting with Josep Borrell Fontelles (High Representative) and 3 other interest representatives

30 Sept 2024 · The objective of the lunch is to gather the views of key representatives from the EU private sector regarding the present situation in Mexico and prospects under the new administration, notably from an economic perspective, in an open dialogue.

Meeting with Andreas Glück (Member of the European Parliament)

16 Sept 2024 · Health

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

24 Jul 2024 · Choroby oddechowe w UE

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Thierry Breton (Commissioner)

19 Mar 2024 · industrial competitiveness of pharma sector

Meeting with Olivier Guersent (Director-General Competition)

5 Mar 2024 · Discussion on IPCEI

Meeting with Angelika Winzig (Member of the European Parliament)

4 Mar 2024 · Pharma Package

Meeting with Dolors Montserrat (Member of the European Parliament)

1 Mar 2024 · Future of pharmaceutical sector in Europe

Response to Report on the review of the implementation of the operations of the Health Emergency Preparedness and Response Authority (HERA) pursuant article 8 of the Commission decision c(2021) 6712 of 16 September establishing HERA.

16 Feb 2024

Meeting with Stella Kyriakides (Commissioner) and 1 other attendee

17 Jan 2024 · Meeting with Mr Roy Papatheodorou, SANOFI Executive Vice President and General Counsel

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 8 other interest representatives

12 Dec 2023 · Directive on Medicinal products for human use

Meeting with Dolors Montserrat (Member of the European Parliament)

17 Nov 2023 · Pharmaceutical Manufacturing in Europe

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur)

10 Nov 2023 · Visite d'usine

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

8 Nov 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

8 Nov 2023

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur)

2 Oct 2023 · Reform of the EU pharmaceutical legislation

Meeting with Salvatore De Meo (Member of the European Parliament)

25 Sept 2023 · Various

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 9 other interest representatives

7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 11 other interest representatives

18 Jul 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 2 other interest representatives

7 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)

Meeting with Karsten Lucke (Member of the European Parliament)

6 Jun 2023 · Health Security Strategy

Meeting with Nicola Beer (Member of the European Parliament, Rapporteur)

6 Jun 2023 · Critical Raw Materials Act

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

31 May 2023 · Directive on Medicinal products for human use

Meeting with Patrizia Toia (Member of the European Parliament)

3 May 2023 · Pharmaceutical strategy

Meeting with Sara Cerdas (Member of the European Parliament)

3 Apr 2023 · Reunião Sanofi Portugal

Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)

27 Mar 2023 · Pharmaceutical legislation and transparency regarding the Advanced Purchase Agreements on vaccines (APA)

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament) and Vaccines Europe

15 Feb 2023 · Pharmaceutical review

Meeting with Frédérique Ries (Member of the European Parliament) and Servier

13 Dec 2022 · Maintenir l'innovation pharmaceutique en Europe et l'accès des patients aux médicaments

Meeting with Andreas Glück (Member of the European Parliament, Committee chair)

7 Dec 2022 · EU Vaccine Strategy

Meeting with Eszter Batta (Cabinet of Commissioner Thierry Breton)

14 Oct 2022 · Pharmaceutical investments, implementation of the Pharma Strategy

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides) and ABDA - Bundesvereinigung Deutscher Apothekerverbände e.V.

7 Sept 2022 · Meeting with the German Pharmaceutical Association and Sanofi to discuss the pharmaceutical reform

Meeting with Karsten Lucke (Member of the European Parliament)

27 Jun 2022 · Initiativen für die Pandemievorsorge / Vorbereitung Jahrestagung House of Pharma & Healthcare

Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)

14 Jun 2022 · R&D, production and manufacturing of essential medicines

Meeting with Dimitri Lorenzani (Cabinet of Vice-President Maroš Šefčovič)

10 Jun 2022 · Discussion on stragegic foresight

Meeting with Karin Karlsbro (Member of the European Parliament) and 3 other interest representatives

17 May 2022 · Pharmaceuticals

Meeting with Andreas Glück (Member of the European Parliament, Committee chair)

11 May 2022 · MDR & IVDR

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

3 Feb 2022 · Initiatives in the health industrial ecosystem

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis), Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis) and 3 other attendees

26 Oct 2021 · Pharmaceutical sector – trade related issues

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

22 Jul 2021

Meeting with Margaritis Schinas (Vice-President) and 15 other attendees

16 Jun 2021 · Supply chains for medicines

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Eszter Batta (Cabinet of Commissioner Thierry Breton)

26 Mar 2021 · Health in the industry policy update

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

24 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on serious cross-border threats to health and repealing Decision No 1082/2013/EU

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

2 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

2 Feb 2021

Meeting with Ursula von der Leyen (President) and 6 other interest representatives

31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements

Response to Revision of the Communication from the Commission — Criteria for the analysis of the compatibility with the internal market of State aid to promote the execution of important projects of common European interest

21 Dec 2020

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

21 Dec 2020

Meeting with Kurt Vandenberghe (Cabinet of President Ursula von der Leyen)

23 Nov 2020 · Alliances

Meeting with Thierry Breton (Commissioner) and 1 other attendee

16 Nov 2020 · Pharmaceutical manufacturing in the EU

Meeting with Pascal Canfin (Member of the European Parliament)

26 Oct 2020 · Covid 19

Meeting with Thierry Breton (Commissioner) and 1 other attendee

13 Oct 2020 · Pharmaceutical manufacturing in the EU

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Meeting with Thierry Breton (Commissioner)

25 May 2020 · Perspectives on the fight against COVID-19

Meeting with Thierry Breton (Commissioner) and 4 other interest representatives

6 Apr 2020 · Digitisation of healthcare and innovative e-health solutions.

Response to Commission Communication on Europe’s Beating Cancer Action Plan

4 Mar 2020

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis) and Novartis International AG

21 Feb 2018 · HTA; Supplementary Protection Certificates (SPC)

Meeting with Lucie Mattera (Cabinet of Commissioner Pierre Moscovici) and Novartis International AG

25 Jan 2018 · European patent protection

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

24 Jan 2018 · HTA; E-Health

Meeting with Manuel Mateo Goyet (Cabinet of Commissioner Mariya Gabriel)

24 Jan 2018 · Digital Healthcare

Meeting with Bernardus Smulders (Cabinet of First Vice-President Frans Timmermans)

10 Oct 2017 · Life Science in the EU

Response to COMMISSION REGULATION (EU) No …/.. amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

14 Oct 2016

Meeting with Clara Martinez Alberola (Cabinet of President Jean-Claude Juncker)

18 Apr 2016 · EPSC, Interinstitutional relations

Meeting with Nils Behrndt (Cabinet of Vice-President Neven Mimica)

18 Apr 2016 · Access to health care including pharmaceuticals in developing countries

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

17 Mar 2016 · AMR, HTA

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

2 Jul 2015 · vaccinations

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and 22 other interest representatives

3 Jun 2015 · New College and Better Regulation

Meeting with Giulia Del Brenna (Cabinet of Commissioner Carlos Moedas)

7 May 2015 · Implementation Council Conclusions on Vaccination

Meeting with Clara Martinez Alberola (Cabinet of President Jean-Claude Juncker)

27 Mar 2015 · How to strengthen a European coherent approach with focus on ERA development, ways to reduce the fragmented approach in Europe for evaluation the value of new medicines for improved access for the patient, and means of creating a more dynamic environment for medicine development in Europe and driving an ambitious agenda allowing the European life sciences sector to remain competetive on a global scale.

Meeting with Juho Romakkaniemi (Cabinet of Vice-President Jyrki Katainen)

19 Mar 2015 · New Commission, Investment plan, TTIP

Meeting with Clara Martinez Alberola (Cabinet of President Jean-Claude Juncker)

19 Feb 2015 · Exchange of views in the perspective to present of Health & Growth and to discuss ERA, medicine development and its access for the patient

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

21 Jan 2015 · A reflection on how Europe can move towards the development of a genuine European Research Area, benefiting from closer cooperation between the private and the academic and public sectors and better exploit the links between fundamental and translational research.